CIK 0001731348 · Large accelerated filer
Tilray Brands, Inc.
Sign in to watch- Ticker
- TLRY
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- May 31
- Entity type
- operating
- EIN
- 824310622
- Phone
- 519.322.8800
- Business address
- 445 PARK AVENUE, NEW YORK, NY, 10022
- Former names
- Tilray, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-01 | Merton Carl A Chief Financial Officer | Returned to the company · Restricted Stock Units ("2023 LTIP RSUs") | −174,477 | 174,477 | ||
| 2024-06-01 | Gendel Mitchell Global General Counsel | Returned to the company · Restricted Stock Units ("2021 LTIP RSUs") | −16,224 | 12,166 | ||
| 2024-06-01 | Gendel Mitchell Global General Counsel | Returned to the company · Restricted Stock Units ("2022 LTIP RSUs") | −105,050 | 0 | ||
| 2024-06-01 | Gendel Mitchell Global General Counsel | Returned to the company · Restricted Stock Units ("2023 LTIP RSUs") | −231,217 | 231,218 | ||
| 2024-06-01 | FALTISCHEK DENISE M Chief Strategy Officer | Returned to the company · Restricted Stock Units ("2021 LTIP RSUs") | −16,224 | 12,166 | ||
| 2024-06-01 | FALTISCHEK DENISE M Chief Strategy Officer | Returned to the company · Restricted Stock Units ("2022 LTIP RSUs") | −123,588 | 0 | ||
| 2024-06-01 | FALTISCHEK DENISE M Chief Strategy Officer | Returned to the company · Restricted Stock Units ("2023 LTIP RSUs") | −249,352 | 249,353 | ||
| 2024-01-19 | Persofsky Renah Director | Returned to the company · Restricted Stock Units | −129,534 | 0 | ||
| 2024-01-17 | FALTISCHEK DENISE M Chief Strategy Officer | Purchase | +10,000 | $2.05 | $21K | 293,269 |
| 2024-01-16 | Gendel Mitchell Global General Counsel | Purchase | +7,200 | $1.98 | $14K | 195,796 |
| 2024-01-12 | Gendel Mitchell Global General Counsel | Purchase | +5,400 | $1.87 | $10K | 188,596 |
| 2024-01-12 | SIMON IRWIN D President and CEO | Purchase | +53,700 | $1.88 | $101K | 2,033,058 |
| 2024-01-12 | Merton Carl A Chief Financial Officer | Purchase | +20,000 | $1.87 | $37K | 20,000 |
| 2023-07-31 | Merton Carl A Chief Financial Officer | Option exercise | +187,852 | $2.53 | $475K | 524,552 |
| 2023-07-31 | Merton Carl A Chief Financial Officer | Shares withheld for taxes | −94,227 | $2.53 | $238K | 430,325 |
| 2023-07-31 | Merton Carl A Chief Financial Officer | Option exercise · Performance-Based Restricted Stock Units ("2022 PSUs") | −93,926 | 93,927 | ||
| 2023-07-31 | SIMON IRWIN D President and CEO | Option exercise | +1,412,428 | $2.53 | $3.6M | 2,760,452 |
| 2023-07-31 | SIMON IRWIN D President and CEO | Shares withheld for taxes | −781,094 | $2.53 | $2.0M | 1,979,358 |
| 2023-07-31 | SIMON IRWIN D President and CEO | Option exercise · Performance-Based Restricted Stock Units ("2022 PSUs") | −706,214 | 706,214 | ||
| 2023-07-31 | Gendel Mitchell Global General Counsel | Option exercise | +187,852 | $2.53 | $475K | 279,095 |
Page 12 of 35 · 686 trades